Animals
Female or male Sprague-Dawley rats (200-220 g) were purchased from Envigo Laboratories (Indianapolis, IN USA). Animals of the same sex were housed 3 per cage with 12-hour light/dark cycles and food/water ad libitum. All experiments were conducted in accordance with the National Institutes of Health, the International Association for the Study of Pain guidelines for laboratory animal welfare, and following the Animal Utilization Protocol #2241 approved by the Saint Louis University Institutional Animal Care and Use Committee.
Test Compounds
Fingolimod (FTY720) and SEW2871 were purchased from Cayman Chemical (Ann Arbor, Michigan). Recombinant rat IL-1β (rrIL-1β) was purchased from Bio-Techne (Minneapolis, Minnesota), MRS1523, [3-propyl-6-ethyl-5[(ethylthio)carbonyl]-2-phenyl-4-propyl-3-pyridinecarboxylate] from Sigma (St. Louis, MO, USA), ABT-702 dihydrochloride 5-(3-Bromophenyl)-7-[6-(4-morpholinyl)-3-pyrido[2,3-d]byrimidin-4-amine dihydrochloride was purchased from Tocris. TASP0277308 was synthesized as previously reported (Fujii et al. 2012a).
Drug Delivery
Drugs were co-administrated in a single i.th. injections performed using the Wilcox method (Hylden and Wilcox 1980): rats were lightly anesthetized with isoflurane and a 50 μL Hamilton syringe (Hamilton, Reno, NV USA) with a 25-ga needle was inserted between the L5/L6 vertebrae puncturing the dura (confirmed by presence of reflexive tail flick and hind limbs) and vehicle or test substance(s) (10 µl) was injected. The vehicle used for all i.th. injections of test agents was 3% (for SEW2871, ABT702 and rrIL-1β), or 15 % (for A-438079) DMSO in saline. The vehicle used for all oral administration of test agents was 5% DMSO/0.5% methylcellulose in water (0.2-mL dosing volume). The vehicle used for i.p. injections was 50% DMSO/saline.
Estrus smears
Rat vaginal smears were taken daily for 7 days before and after the experiment to verify normal cyclicity. Cells were placed on a glass slide and analyzed with a light microscope to determine their stage of estrus cycle as described (Byers et al. 2012). All animals displayed a normal 4- to 5-day estrus cycle.
Chronic Constriction Injury (CCI) model of neuropathic pain
CCI to the sciatic nerve of the left hind leg in rats was performed under general anesthesia using the method described by Bennett et al. (Bennett and Xie 1988). Briefly, rats (weighing 200–250 g at the time of surgery) were anesthetized with 3% isoflurane/O2 inhalation and maintained on 2% isoflurane/O2 for the duration of surgery. The left thigh was shaved and scrubbed with dermachlor solution (0.2% chlorhexidine gluconate), and a small incision (1–1.5 cm in length) was made in the middle of the lateral aspect of the thigh to expose the sciatic nerve. The nerve was loosely ligated at 3 sites spaced 1 mm apart using 4.0 silk sutures. The surgical site was closed with a skin clip.
Behavioral testing
Mechanical allodynia as a readout was assessed as the hind paw withdrawal response to von Frey hair stimulation using the up-and-down method (Dixon 1980). Briefly, the animals were first acclimatized (30 minutes) in individual clear Plexiglas boxes on an elevated wire mesh platform to facilitate access to the plantar surface of the hind paws. Subsequently, a series of von Frey hairs (1.4, 2, 4, 6, 8, 10, 15, 26 g; Stoelting, Wood Dale, IL USA) were applied perpendicular to the plantar surface of the hind paw, until the filament buckles, for 2–5 s. A test began with the application of the 4 g for rats. A positive response was defined as clear paw withdrawal or shaking. In the event of a positive response, the next lighter hair was applied, whereas the next higher hair was applied in the event of a negative response. At least three readings are obtained after the first positive response and the pattern of response was converted to a 50% paw withdrawal threshold (PWT), using the method described by Chaplan (Chaplan et al. 1994). Mechano-allodynia was defined as a significant (2 SD) decrease in the measured behavior compared to the individual animal’s baseline behavior prior to mechanical or pharmacological pain induction.
Western blot analysis
Animals were sacrificed under anesthesia through transcardiac perfusion with cold phosphate-buffered saline (PBS). The dorsal lower lumbar enlargement (L4-L6) of the spinal cord was harvested and flash-frozen in liquid nitrogen. Samples were homogenized, and protein concentrations were determined by bicinchoninic acid (BCA) protein assay (Thermo-Fisher, Waltham, MA). Proteins were denatured in Laemmli buffer and boiled for 5 minutes. Equal amounts of proteins (50 µg or 10 µg) were loaded and resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to polyvinylidene fluoride membranes. Membranes were blocked for 2 hours at room temperature in 3% bovine serum albumin (BSA) in 1X TBS-T. Anti-NLRP3 (1:1000; Novus Biologicals, Littleton, Colorado, #NBP2-12446), anti-caspase 1 (p20) (1:1000; Santa Cruz Biotechnology, Santa Cruz, California, #sc-398715) and anti-IL-1β antibody (1:1000, Cell Signaling, Danvers, Massachusetts, #12242), anti-adenosine kinase (1:1000; Thermo Fisher Scientific, Waltham, Massachusetts, #PA5-27399) were diluted in 1.5% BSA in 1X TBS-T, and membranes were incubated overnight at 4°C. The bound antibodies were visualized after incubation with peroxidase-conjugated goat anti-rabbit IgG (1:5000, Cell Signaling, #7074) or peroxidase-conjugated bovine anti-mouse IgG secondary antibody (1:5000, Jackson ImmunoResearch, #04-18-15) for 1 hour at RT. Peroxidase-conjugated antibodies were visualized by enhanced chemiluminescence (Bio-Rad, Hercules, CA). Chemiluminescence antibody signals were documented using Chemidoc XRS+ image system and ImageLab software (BioRad) using exposure settings and quantified for band densitometry. Each membrane was then probed for β-actin (1:5000, Sigma-Aldrich, St. Louis, MO, #A5441) as endogenous loading controls. The antibody used to probe for NLRP3, IL-1β, caspase 1 (p20), adenosine kinase detect the same bands as reported in a previous publications (Doyle et al. 2019; Wahlman et al. 2018). Relative protein expression was quantified by measuring band densitometry. Images for the blots of a protein of interest and their corresponding β-actin were selected for analyses and presentation based on a predetermined upper grayscale value (45000-65000 units) in order to assure linear densitometric values. Images were analyzed using the lane and band functions of the ImageLab™ software. For presentation purposes, the grayscale range was set between 0 units and the predetermined upper grayscale value (45000-65000 units) for the protein of interest and corresponding β-actin prior to exporting as an image file. Post-export modifications of the images were limited to cropping to the regions of interest.
Immunofluorescence
Immunofluorescence was performed using modifications of previously reported methods (Wahlman et al. 2018). After behavioral measurements, rats were perfused with 4%PFA and the lower lumbar enlargement of the spinal cord (L4-L6) was harvested. Tissue was fixed for 30 min with 4% PFA in 1X PBS, washed with PBS and cryoprotected in 30% sucrose before embedding in OCT, and frozen in 2-methylbutane and liquid nitrogen bath. Transverse sections (20 mm) were cut using a cryostat and collected on glass microscope slides. Spinal cord sections were fixed in 4% PFA (10 minutes), blocked (5% donkey serum, 0,5% bovine serum albumin in 1X PBS, for 1 hour), and then immunolabeled using an 18-hour incubation (4°C) with rabbit polyclonal anti-ADK (1:100; Thermo Fisher Scientific, Waltham, Massachusetts, #PA5-27399) and antiglial fibrillary acidic protein (GFAP) (1:1000; Sigma-Aldrich, St. Louis, MO, #G3893). After a series of PBS rinses, sections were incubated for 2 hours with donkey antirabbit Alexa Fluor 594 conjugated (1:250; Jackson ImmunoResearch, #711-585-152) and anti-mouse Alexa Fluor 488 conjugated antibody (1:250; Jackson ImmunoResearch, #715-545-151). The coverslips were mounted with Prolong Gold antifade reagent containing DAPI [4,6-Diamidino-2-phenylindole, dihydrochloride] to label nuclei (Electron Microscopy Sciences, Hatfield, PA). Immunofluorescence images were captured on a Leica TCS SP8 Confocal microscope (Leica Microsystems, Exton, PA) using a 20x lens (0.75 NA) using the same laser power and detector gain for all animals. 8 bit images were collected at 1024x768 resolution and analyzed using the SVI Huygens Object Analysis module (SVI, Netherlands). GFAP and adenosine antibodies were used in a previous publication (Wahlman et al. 2018). GFAP signal in hand selected areas representing lamina 1 and 2 was used to create a ROI for measuring intensity and counting numbers of voxels corresponding to a volume of ADK encompassing the GFAP signal + 1 micrometer of surrounding area in order to approximate astrocytes. One animal from the SEW group was excluded as a clear outlier based on ADK signal out of observed ranges seen for either treatment group. Example images produced using Surface Visualization module of SVI Huygens with the same thresholding applied to both images.
UHPLC-MS/HRMS Analysis for Adenosine and Inosine
All solvents were of LC-MS or better quality. Water with 0.1 % FA and MeOH with 0.1 % FA were purchased from Honeywell Chromasolv™ (Charlotte, NC, USA). Adenosine standard was purchased from ACROS Organics (New Jersey, USA). Inosine standard was purchased from Millipore Sigma (Darmstadt, Germany). Adenosine-13C5 was purchased from Toronto Research Chemicals (Toronto, ON, Canada). Inosine-15N4 was purchased from Cambridge Isotope Laboratories (Tewkesbury, MA, USA).
Combined adenosine and inosine stock solution was prepared in 17:3 H2O:MeOH + 0.1 % FA at 1 mM from 5 mM individual stocks in same. Calibration standards were prepared in same from 50 nM to 100 μM in half-order of magnitude increments via serial dilution from combined stock (e.g. 50 nM, 100 nM, 500 nM, 1 μM etc.), as were QC standards at 2.5 and 25 μM.
The IS was made at 10 μg/mL in 17:3 H2O:MeOH + 0.1 % FA from 1 mg/mL individual stocks of adenosine-13C5 and inosine-15N4 in 19:1 H2O:MeOH + 0.1 % FA.
All samples were injected as extracted by third party (PCA protein precipitation and KOH neutralization), with the addition of IS 3:17 (IS:sample extract).
All analyses were performed on a Dionex UltiMate™ 3000 UHPLC coupled to a Thermo Q Exactive™ Plus Hybrid Quadrupole-Orbitrap™ MS.
Column used was a Phenomenex Kinetex PFP, 1.7 μm, 2.1 x 150 mm. Mobile phase A was 0.1 % FA in H2O; mobile phase B was 0.1 % FA in MeOH. Isocratic elution at 15 % B was accomplished in 2 min with a 500 μL/min flow rate and a column temperature of 45 °C. Injection volume was 2 μL.
Negative Heated ESI (HESI) parameters were as follows: -3.0 kV spray voltage, 40 % S-lens, 50 au sheath gas, 15 au auxiliary gas, 1 au sweep gas, 350 °C capillary temperature & 275 °C HESI probe temperature.
LC-MS/MS assay for nucleotides
The assay covered the analysis of NAM, NMN, 1-methyl NAM, NAD, NADPH, ATP, GTP, CTP, TTP, UTP, IMP, AMP, CMP, GMP, UMP, and TMP. Detailed protocols for LC-MS/MS assays of oxidized nucleotides were described elsewhere (Petucci et al. 2019).
An aliquot of biological fluid, cell homogenate, or tissue homogenate was quenched with equal volume of 1M PCA and spiked with a mixture of heavy isotope-labeled, nucleotide internal standards followed by the addition of 1M ammonium formate. Samples were vortexed and centrifuged at 18,000 x g for 5 min at 10 °C. and then filtered through an AcroPrep Advance 3K Omega Filter Plate (Pall Corporation) by centrifugation at 3500 x g for 60 min prior to LC-MS/MS analysis. Metabolites were separated on a 2.1 x 50 mm, 3 μm Thermo Scientific Hypercarb column (T = 30°C) using a Dionex Ultimate 3000 UHPLC. The step gradient was 98% A (10 mM ammonium acetate, pH 9.5) and 2% B (ACN) to 64 % A and 36% B over 6.3 min. The step gradient began at 2% B (0.6 ml min-1 flow rate) from 0-0.45 min, was increased from 2% to 36% B (0.6 ml min-1 flow rate) from 0.45-6.3 min, was increased from 36% to 95% B (0.8 ml min-1 flow rate) from 6.3-6.4 min, and was held until 8.4 min. Re-equilibration was performed at 2% B from 8.4-8.5 min (0.7 ml min-1 flow rate) and was held until 11.5 min. The flow returned to 0.6 ml min-1 at 11.6 min and was held until 11.7 min. Quantitation of pyridine nucleotides was achieved using single reaction monitoring (SRM) on a Thermo Scientific Quantiva triple quadrupole mass spectrometer (Thermo Scientific). The mass spectrometer was operated in positive ion mode using electrospray ionization with an ESI capillary voltage of 3500 V. The ion transfer tube temperature was 350 °C and vaporizer temperature was 350°C. The ESI source sheath gas was set to 40, the auxiliary gas was set to 10, and the sweep gas was set to 1. The mass spectrometer was operated with a mass resolution of 0.7 Da, a cycle time of 0.3 s, and nitrogen collision gas of 1.5 mTorr for the generation and detection of product ions of each nucleotide. Collision energies to produce product ions ranged from 16-46 V with RF lens values ranging from 43-85 V.
S1PR1 functional assay
To evaluate the MRS1523 activity on S1PR1, S1PR1 Lysophospholipid (S1P) GPCR cell-based antagonist β-Arrestin assay (The PathHunter® β-Arrestin assay; Eurofins Discovery, Fremont, CA) was performed following the manufacturer's instructions. β-Arrestin recruitment was measured in cells expressing S1PR1. Data was normalized to the maximal and minimal response observed in the presence of EC80 ligand and vehicle. The following EC80 concentrations were used: mEDG1 Arrestin: 0.065μM S1P (Fig. 2e). Percentage inhibition was calculated using the following formula: % Inhibition =100% x (1 - (mean RLU of test sample - mean RLU of vehicle control) / (mean RLU of EC80 control - mean RLU of vehicle control)).Compound activity was analyzed using CBIS data analysis suite (ChemInnovation, CA).
Statistical Analysis
Data are expressed as mean ± SD. No differences were observed between male and female rats behavior (p < 0.05) and therefore, where indicated, data were expressed as a single group. Justification for animal numbers was consistent with NIH policy (NOT-OD-15-102), and experiments were randomized to blinded treatment groups, giving 80% power to detect a treatment effect size of 20% compared to a baseline response of 5% at a significance level of 0.05 (Andrews et al. 2016). Behavioral data were analyzed by student’s t test, one-way, two-way, or repeated measures ANOVA with Dunnett’s or Tukey’s pair-wise comparisons. Protein expression data was determined by two-tailed, one-way ANOVA with Tukey’s comparisons. All statistical analyses were performed using GraphPad Prism version 9.0 (Graph Pad Inc., San Diego, CA).